LAMA, BARBARA
LAMA, BARBARA
DIPARTIMENTO DI INFORMATICA - SCIENZA E INGEGNERIA
Personale tecnico amm.vo
A phase I study of Tipifarnib and Bortezomib in the treatment of poor risk adult acute myeloid leukemia (AML)
2014 Cristina Papayannidis, Stefania Paolini, Barbara Lama, Emanuela Ottaviani, Federica Salmi, Ilaria Iacobucci, Antonio Curti, Daniela Cilloni, Sarah Parisi, Giuseppe Saglio, Renato Fanin, Fortunato Morabito, Maria Pantaleo, Pier Luigi Lollini, Michele Baccarani, Giovanni Martinelli
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience
2009 Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandra; Lonetti, Annalisa; Baldazzi, Carmen; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Castagnetti, Fausto; Poerio, Angela; Clissa, Cristina; Parisi, Sarah; Polverelli, Nicola; Guadagnuolo, Viviana; Pier Paolo Piccaluga, ; Rosti, Gianantonio; Baccarani, Michele; Martinelli, Giovanni
Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study
2011 Mariachiara Abbenante, Cristina Papayannidis, Ilaria Iacobucci, Anna Candoni, Stefania Paolini, Michele Malagola, Ottaviani Emanuela, Annalisa Lonetti, Antonio Curti, Sarah Parisi, Nicoletta Testoni, Barbara Lama, Michele Baccarani, Giovanni Martinelli
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients
2012 Viviana Guadagnuolo; Cristina Papayannidis; Ilaria Iacobucci; Sandra Durante; Carolina Terragna; Emanuela Ottaviani; Maria Chiara Abbenante; Federica Cattina; Simona Soverini; Barbara Lama; Lucia Toni; Wendy Levin; Rachel Courtney; Carmen Baldazzi; Antonio Curti; Michele Baccarani; Catriona Jamieson; Jorge Cortes; Vivian Oehler; Karen McLachlan; Todd VanArsdale; Giovanni Martinelli
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients
2014 Cristina Papayannidis, Ilaria Iacobucci, Simona Soverini, Stefania Paolini, Sandra Santucci, Daniela Cilloni, Francesca Messa, Fabrizio Pane, Vittorio Meneghini, Panagiota Giannoulia, Emanuela Ottaviani, Nicoletta Testoni, Barbara Lama, Maria Pantaleo, Michele Baccarani, Giovanni Martinelli
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients
2012 Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cattina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G.
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients
2011 Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli
RASGRP1/APTX ratio is a strong biomarker which predicts response to therapy with Tipifarnib plus Bortezomib in elderly patients with Acute Myeloid Leukemia (AML)
2014 Cristina Papayannidis, Stefania Paolini, Emanuela Ottaviani, Federica Salmi, Barbara Lama, Antonio Curti, Ilaria Iacobucci, Sarah Parisi, Cristina Clissa, Pier Paolo Piccaluga, Daniela Cilloni, Giuseppe Saglio, Anna Candoni, Fortunato Morabito, Carlo Finelli, Nicola Vianelli, Mitch Raponi, Massimo Serra, Michele Baccarani, Giovanni Martinelli
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A phase I study of Tipifarnib and Bortezomib in the treatment of poor risk adult acute myeloid leukemia (AML) | Cristina Papayannidis, Stefania Paolini, Barbara Lama, Emanuela Ottaviani, Federica Salmi, Ilaria... Iacobucci, Antonio Curti, Daniela Cilloni, Sarah Parisi, Giuseppe Saglio, Renato Fanin, Fortunato Morabito, Maria Pantaleo, Pier Luigi Lollini, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience | Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandr...a; Lonetti, Annalisa; Baldazzi, Carmen; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Castagnetti, Fausto; Poerio, Angela; Clissa, Cristina; Parisi, Sarah; Polverelli, Nicola; Guadagnuolo, Viviana; Pier Paolo Piccaluga, ; Rosti, Gianantonio; Baccarani, Michele; Martinelli, Giovanni | 2009-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study | Mariachiara Abbenante, Cristina Papayannidis, Ilaria Iacobucci, Anna Candoni, Stefania Paolini, M...ichele Malagola, Ottaviani Emanuela, Annalisa Lonetti, Antonio Curti, Sarah Parisi, Nicoletta Testoni, Barbara Lama, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients | Viviana Guadagnuolo; Cristina Papayannidis; Ilaria Iacobucci; Sandra Durante; Carolina Terragna; ...Emanuela Ottaviani; Maria Chiara Abbenante; Federica Cattina; Simona Soverini; Barbara Lama; Lucia Toni; Wendy Levin; Rachel Courtney; Carmen Baldazzi; Antonio Curti; Michele Baccarani; Catriona Jamieson; Jorge Cortes; Vivian Oehler; Karen McLachlan; Todd VanArsdale; Giovanni Martinelli | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients | Cristina Papayannidis, Ilaria Iacobucci, Simona Soverini, Stefania Paolini, Sandra Santucci, Dani...ela Cilloni, Francesca Messa, Fabrizio Pane, Vittorio Meneghini, Panagiota Giannoulia, Emanuela Ottaviani, Nicoletta Testoni, Barbara Lama, Maria Pantaleo, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients | Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cat...tina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G. | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients | Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, ...Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| RASGRP1/APTX ratio is a strong biomarker which predicts response to therapy with Tipifarnib plus Bortezomib in elderly patients with Acute Myeloid Leukemia (AML) | Cristina Papayannidis, Stefania Paolini, Emanuela Ottaviani, Federica Salmi, Barbara Lama, Antoni...o Curti, Ilaria Iacobucci, Sarah Parisi, Cristina Clissa, Pier Paolo Piccaluga, Daniela Cilloni, Giuseppe Saglio, Anna Candoni, Fortunato Morabito, Carlo Finelli, Nicola Vianelli, Mitch Raponi, Massimo Serra, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |